Q2 revenue rises 39.6%, profit rises 10%, cash flow turns negative
INDGN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts more than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q2 revenue rose 39.6% to INR 11,223 million; profit after tax rose 10% to INR 1,123 million. First-half revenue was INR 21,854 million and profit INR 2,285 million, including Cake Group. First-half operating cash flow was negative INR 133 million versus positive INR 2,028 million. The review was unmodified. A prior-year litigation charge was an exceptional item. A director and company secretary resigned. Segment figures were recast.
Revenue growth is strong, but slower profit growth, negative operating cash flow and leadership departures may weigh on the stock.